Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease

Key Inclusion Criteria: * Healthy male or female subject ≥18 years of age * Presence of moderate DED in at least one eye Key Exclusion Criteria: * Presently using prescription eyedrops, except those used for DED, which must be discontinued 2 weeks prior * Use of OTC eyedrops except for lubricant eyedrops or artificial tears, within 1 week prior to initiation of study drug dosing * External eye disease except primary DED * Systemic disease associated with DED * History or evidence of ocular infection within the previous 30 days * History or evidence of ocular herpes simplex or ocular herpes zoster * Blepharitis or meibomian gland disease requiring the use of either topical or systemic antibiotics within 2 months